301 related articles for article (PubMed ID: 34656690)
1. Blood-based liquid biopsy: Insights into early detection and clinical management of lung cancer.
Liu C; Xiang X; Han S; Lim HY; Li L; Zhang X; Ma Z; Yang L; Guo S; Soo R; Ren B; Wang L; Goh BC
Cancer Lett; 2022 Jan; 524():91-102. PubMed ID: 34656690
[TBL] [Abstract][Full Text] [Related]
2. Circulating microRNA signature as liquid-biopsy to monitor lung cancer in low-dose computed tomography screening.
Sestini S; Boeri M; Marchiano A; Pelosi G; Galeone C; Verri C; Suatoni P; Sverzellati N; La Vecchia C; Sozzi G; Pastorino U
Oncotarget; 2015 Oct; 6(32):32868-77. PubMed ID: 26451608
[TBL] [Abstract][Full Text] [Related]
3. The Present and Future of Liquid Biopsies in Non-Small Cell Lung Cancer: Combining Four Biosources for Diagnosis, Prognosis, Prediction, and Disease Monitoring.
Bracht JWP; Mayo-de-Las-Casas C; Berenguer J; Karachaliou N; Rosell R
Curr Oncol Rep; 2018 Jul; 20(9):70. PubMed ID: 30030656
[TBL] [Abstract][Full Text] [Related]
4. Liquid biopsy: Circulating exosomal long noncoding RNAs in cancer.
Jiang N; Pan J; Fang S; Zhou C; Han Y; Chen J; Meng X; Jin X; Gong Z
Clin Chim Acta; 2019 Aug; 495():331-337. PubMed ID: 31054913
[TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy for lung cancer screening: Usefulness of circulating tumor cells and other circulating blood biomarkers.
Hofman P
Cancer Cytopathol; 2021 May; 129(5):341-346. PubMed ID: 33007153
[TBL] [Abstract][Full Text] [Related]
6. Exosomal Non Coding RNA in LIQUID Biopsies as a Promising Biomarker for Colorectal Cancer.
Baassiri A; Nassar F; Mukherji D; Shamseddine A; Nasr R; Temraz S
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32092975
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA Based Liquid Biopsy: The Experience of the Plasma miRNA Signature Classifier (MSC) for Lung Cancer Screening.
Mensah M; Borzi C; Verri C; Suatoni P; Conte D; Pastorino U; Orazio F; Sozzi G; Boeri M
J Vis Exp; 2017 Oct; (128):. PubMed ID: 29155727
[TBL] [Abstract][Full Text] [Related]
8. [Progress of Liquid Biopsy in Early Diagnosis of Lung Cancer].
Song Z; Liu Y
Zhongguo Fei Ai Za Zhi; 2018 Aug; 21(8):620-627. PubMed ID: 30172270
[TBL] [Abstract][Full Text] [Related]
9. Liquid biopsy for early detection of lung cancer.
Hofman P
Curr Opin Oncol; 2017 Jan; 29(1):73-78. PubMed ID: 27906860
[TBL] [Abstract][Full Text] [Related]
10. Diagnosing Lung Cancers through Examination of Micro-RNA Biomarkers in Blood, Plasma, Serum and Sputum: A Review and Summary of Current Literature.
Gyoba J; Shan S; Roa W; Bédard EL
Int J Mol Sci; 2016 Apr; 17(4):494. PubMed ID: 27043555
[TBL] [Abstract][Full Text] [Related]
11. Circulating biomarkers for early detection and clinical management of colorectal cancer.
Marcuello M; Vymetalkova V; Neves RPL; Duran-Sanchon S; Vedeld HM; Tham E; van Dalum G; Flügen G; Garcia-Barberan V; Fijneman RJ; Castells A; Vodicka P; Lind GE; Stoecklein NH; Heitzer E; Gironella M
Mol Aspects Med; 2019 Oct; 69():107-122. PubMed ID: 31189073
[TBL] [Abstract][Full Text] [Related]
12. Circulating epigenetic biomarkers in lung malignancies: From early diagnosis to therapy.
Tomasetti M; Amati M; Neuzil J; Santarelli L
Lung Cancer; 2017 May; 107():65-72. PubMed ID: 27312601
[TBL] [Abstract][Full Text] [Related]
13. Circulating long noncoding RNA act as potential novel biomarkers for diagnosis and prognosis of non-small cell lung cancer.
Xie Y; Zhang Y; Du L; Jiang X; Yan S; Duan W; Li J; Zhan Y; Wang L; Zhang S; Li S; Wang L; Xu S; Wang C
Mol Oncol; 2018 May; 12(5):648-658. PubMed ID: 29504701
[TBL] [Abstract][Full Text] [Related]
14. Serum and blood based biomarkers for lung cancer screening: a systematic review.
Chu GCW; Lazare K; Sullivan F
BMC Cancer; 2018 Feb; 18(1):181. PubMed ID: 29439651
[TBL] [Abstract][Full Text] [Related]
15. Liquid biopsies based on DNA methylation as biomarkers for the detection and prognosis of lung cancer.
Li P; Liu S; Du L; Mohseni G; Zhang Y; Wang C
Clin Epigenetics; 2022 Sep; 14(1):118. PubMed ID: 36153611
[TBL] [Abstract][Full Text] [Related]
16. Liquid Biopsy in Lung Cancer: Biomarkers for the Management of Recurrence and Metastasis.
Souza VGP; Forder A; Brockley LJ; Pewarchuk ME; Telkar N; de Araújo RP; Trejo J; Benard K; Seneda AL; Minutentag IW; Erkan M; Stewart GL; Hasimoto EN; Garnis C; Lam WL; Martinez VD; Reis PP
Int J Mol Sci; 2023 May; 24(10):. PubMed ID: 37240238
[TBL] [Abstract][Full Text] [Related]
17. Liquid biopsy and PCR-free ultrasensitive detection systems in oncology (Review).
Finotti A; Allegretti M; Gasparello J; Giacomini P; Spandidos DA; Spoto G; Gambari R
Int J Oncol; 2018 Oct; 53(4):1395-1434. PubMed ID: 30085333
[TBL] [Abstract][Full Text] [Related]
18. A circulating non-coding RNA panel as an early detection predictor of non-small cell lung cancer.
Peng H; Wang J; Li J; Zhao M; Huang SK; Gu YY; Li Y; Sun XJ; Yang L; Luo Q; Huang CZ
Life Sci; 2016 Apr; 151():235-242. PubMed ID: 26946307
[TBL] [Abstract][Full Text] [Related]
19. Circulating Cell-Free Nucleic Acids: Main Characteristics and Clinical Application.
Szilágyi M; Pös O; Márton É; Buglyó G; Soltész B; Keserű J; Penyige A; Szemes T; Nagy B
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32957662
[TBL] [Abstract][Full Text] [Related]
20. Circulating MicroRNAs as Potential Biomarkers for Lung Cancer.
Müller S; Janke F; Dietz S; Sültmann H
Recent Results Cancer Res; 2020; 215():299-318. PubMed ID: 31605236
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]